Fig. 4From: Therapeutic effects of Lucilia sericata larval excretion/secretion products on Leishmania major under in vitro and in vivo conditionsNumber of Leishmania major promastigotes per milliliter upon exposure to different concentrations of the crude and fractionated ES compared with Glucantime at three time points (24, 48 and 72 h). Data are presented as means ± SD; means are significantly different at P < 0.05Back to article page